The notion of obliterating the LAA grew out of the knowledge that most of the systemic emboli leading to stroke in patients with AF originate from the LAA. LAA exclusion was first attempted surgically ...

Rochester, MN - A case report of a patient who suffered erosion of an Amplatzer septal-occluder device (St Jude Medical) six years after it was implanted, resulting in cardiac tamponade and ...

At 2-year follow-up, a septal occluder device was deemed safe and effective for transcatheter closure of atrial septal defects, according to new data published in Circulation: Cardiovascular ...

MINNEAPOLIS, Sept. 10 AGA Medical Corporation ("AGA")announced today that it has received U.S. Food and Drug Administration (FDA)approval to market the AMPLATZER Muscular Ventricular Septal (VSD) ...

Figure 1 - With fluoroscopic and echocardiographic guidance, the cardiologist inserts the device through the hole in the septum. The device is then partially deployed. As it is deployed from the ...

A novel study by Canadian physicians reported that the BioSTAR biodegradable implant achieved comparable closure rates to the Amplatzer Septal Occluder in children with atrial septal defect. A novel ...

St. Jude Medical ($STJ) got sideswiped with an FDA safety alert over one of the company's heart plugs based on reports that it could potentially wear away tissue and ...

Muscular ventricular septal defects (mVSD) appearing together with other septal defects are frequently regarded as ‘concomitant’ pathologies, that nevertheless should be considered while the patient ...

Perimembranous ventricular septal defects (VSDs) involving the membranous septum and the adjoining muscular septum are the most common form of congenital heart defect. Traditional surgical repair ...